Jay Bradner's Leadership and Research Vision at Novartis

This article is a profile of Jay Bradner, the new President of the Novartis Institutes for BioMedical Research (NIBR), detailing his journey in biomedical research and his vision for drug discovery. It outlines Bradner's background, including his experiences as a stem cell transplant doctor and his academic roles, which have shaped his approach to research with clinical applications. The text highlights his commitment to developing definitive treatments for various diseases, emphasizing the importance of innovative technologies in modern research. Bradner discusses his leadership style, which values trust, curiosity, and collaboration among scientists. He also reflects on the principles of open-source science, describing how this approach has accelerated drug discovery and fostered a collaborative research environment. The article concludes with Bradner's aspirations for NIBR and the potential for impactful medical advancements in the coming years.